Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page

Investor Relations

Events & Presentations

Apr 24, 2014 at 11:00 AM ET
Q1 2014 Sigma-Aldrich Corporation Earnings Conference Call
Listen to Webcast Listen to Webcast
PDF View Presentation  271.0 KB   Add to Briefcase

View all events & presentations »

Corporate Profile

Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 40 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at .

Recent Releases

Apr 24, 2014
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q1 2014 Results With Sales Of $689 Million And Adjusted Diluted EPS Of $1.06. Reaffirms Full-Year 2014 Adjusted Diluted EPS Guidance Of $4.30 To $4.40.

Apr 16, 2014
Cerilliant Introduces New Certified Snap-N-Spike® Solutions of Corticosteroids

Apr 4, 2014
Sigma-Aldrich Announces Q1 2014 Earnings Conference Call

View all releases »

Featured Documents

© 2014 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher